About
Glykos is a biopharmaceutical company in Helsinki, Finland developing antibody-drug conjugates for hematologic and solid tumor targets. It also provides glycan and glycoprotein analytical services using mass spectrometry and related techniques for pharmaceutical and research customers.
Services
Analytical services
High-throughput analytical services to characterize glycans of proteins, biomolecules, cells, and tissues using mass spectrometry, chromatography, microarrays, and NMR spectroscopy.
Glycan profiling
High-throughput analysis of N-linked and O-linked glycans on antibodies and other glycoproteins, including qualitative and quantitative glycan profiling.
Full structural glycan analysis
Structural analysis of glycans using mass spectrometric and complementary analytical methods.
ADC technology development
Development of next-generation antibody-drug conjugate technologies using hydrophilic linker and payload platforms.
Dual-payload ADC development
Development of dual-payload antibody-drug conjugates combining complementary cytotoxic mechanisms with site-specific conjugation.
Glycan structural characterization
Structural analysis of glycan structures using mass spectrometric fragmentation, glycosidase sequencing, and NMR spectroscopy.
Customized glycan analyses
Custom glycan analysis services tailored to client needs.
- What to send
- Samples for glycan analysis
Capabilities
- Assays and studies
- ADCs
- Antibodies
- NMR
- Mass spectrometric glycan profiling
- Full structural analysis of glycans
- Glycan and protein microarrays
7 more
- Fluorescence-activated cell sorting
- NMR spectroscopy
- Microanalytical chromatography
- MALDI-TOF mass spectrometry
- Glycan structural analysis
- Mass spectrometric fragmentation
- Glycosidase sequencing
- Scale and capacity
- 96-well format sample processing
- Hundreds to thousands of samples
- Large sample sets from hundreds to thousands of samples
- Therapeutic areas
- Oncology
- Hematologic cancers
- Solid tumors
- AML
- MM
- Hematologic malignancies
Instruments and platforms
- MALDI-TOF mass spectrometry
- Mass spectrometry
- NMR spectroscopy
Modalities and species
- Modalities
- Antibody
- ADC
- Species and models
- Human stem cells
- Cancer stem cells
- Cells
- Tissues
- Human stem cell types
Industries served
- Biopharmaceutical
- Pharmaceutical
- Research institutions
Details
- Based in
- Helsinki, Finland
- Phone
- +358 9 3193 6340
Public records
- Parent company
- Glykos Holding Oy · FI GLEIF